Literature DB >> 6810178

Hypertrophic obstructive cardiomyopathy due to Fabry's disease.

W S Colucci, B H Lorell, F J Schoen, M J Warhol, W Grossman.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 6810178     DOI: 10.1056/NEJM198210073071505

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Mid-ventricular obstruction occurred in hypertrophic left ventricle of heterozygous Fabry's disease-Favorable effects of cibenzoline: A case report.

Authors:  Shinya Nishizawa; Tomoko Osamura; Norikazu Takechi; Shigehiro Kusuoka; Keizo Furukawa
Journal:  J Cardiol Cases       Date:  2011-09-07

2.  Short PR intervals and tachyarrhythmias in Fabry's disease.

Authors:  J Efthimiou; J McLelland; D J Betteridge
Journal:  Postgrad Med J       Date:  1986-04       Impact factor: 2.401

3.  Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.

Authors:  M Elleder; V Bradová; F Smíd; M Budĕsínský; K Harzer; B Kustermann-Kuhn; J Ledvinová; V Král; V Dorazilová
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.

Authors:  José-Luis E Velazquez-Ceceña; David L Lubell; Nagapradeep Nagajothi; Hytham Al-Masri; Mumtaz Siddiqui; Sandeep Khosla
Journal:  Tex Heart Inst J       Date:  2009

5.  Postmortem diagnosis of Fabry disease with acromegaly and a unique vasculopathy.

Authors:  Masaki Takao; Taisuke Mori; Hideki Orikasa; Haengphil Oh; Kinuko Suzuki; Atsuo Koto; Kazuto Yamazaki
Journal:  Virchows Arch       Date:  2007-07-12       Impact factor: 4.064

6.  Cardiac manifestations in patients with classical or cardiac subtype of Fabry disease.

Authors:  Wei-Ting Wang; Shih-Hsien Sung; Jo-Nan Liao; Ting-Rong Hsu; Dau-Ming Niu; Wen-Chung Yu
Journal:  J Chin Med Assoc       Date:  2020-09       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.